Veterinary Medicines

NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER

Authorised
  • Turkey rhinotracheitis virus, strain PL21, Live
Download as PDF

Product identification

Medicine name:
NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER
Nemovac
Active substance:
  • Turkey rhinotracheitis virus, strain PL21, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain PL21, Live
    2.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Box of one 1000-dose bottle
  • Box of ten 5000-dose bottles
  • Box of one 5000-dose bottles
  • Box of ten 2000-dose bottles
  • Box of one 2000-dose bottle
  • Box of ten1000-dose bottle,

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 646/99 DGV
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0353/001
Concerned member states:
  • Austria
  • Germany
  • Greece
  • Ireland
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 18/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."